1 – 20 of 20
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
ICTV virus taxonomy profile : Papillomaviridae
(
- Contribution to journal › Article
- 2017
-
Mark
North Andean origin and diversification of the largest ithomiine butterfly genus
(
- Contribution to journal › Article
- 2010
-
Mark
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
(
- Contribution to journal › Article
-
Mark
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women.
(
- Contribution to journal › Article
-
Mark
Commissioning of the ATLAS Muon Spectrometer with cosmic rays
(
- Contribution to journal › Article
-
Mark
The ATLAS Simulation Infrastructure
(
- Contribution to journal › Article
-
Mark
Readiness of the ATLAS liquid argon calorimeter for LHC collisions
(
- Contribution to journal › Article
-
Mark
Drift Time Measurement in the ATLAS Liquid Argon Electromagnetic Calorimeter using Cosmic Muons
(
- Contribution to journal › Article
-
Mark
Charged-particle multiplicities in pp interactions at root s=900 GeV measured with the ATLAS detector at the LHC ATLAS Collaboration
2010) In Physics Letters. Section B: Nuclear, Elementary Particle and High-Energy Physics 688(1). p.21-42(
- Contribution to journal › Article
-
Mark
Performance of the ATLAS detector using first collision data
(
- Contribution to journal › Article
- 2009
-
Mark
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
(
- Contribution to journal › Article
-
Mark
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
(
- Contribution to journal › Article
-
Mark
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 Years
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2008
-
Mark
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
(
- Contribution to journal › Article
-
Mark
Combined performance tests before installation of the ATLAS Semiconductor and Transition Radiation Tracking Detectors
(
- Contribution to journal › Article
- 2007
-
Mark
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
(
- Contribution to journal › Article
-
Mark
Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection
(
- Contribution to journal › Article
-
Mark
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
(
- Contribution to journal › Article
- 2006
-
Mark
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
(
- Contribution to journal › Article